Background
==========

Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions \[[@B1],[@B2]\]. The causal factor of excessive free trimethylamine is reduced enzyme capacity, or maybe substrate overload. The decreased enzyme capacity to form non-odorous trimethylamine *N*-oxide could be a result by an inherited deficiency (primary genetic trimethylaminuria) and/or by hormonal modulation or liver damage (transient trimethylaminuria) \[[@B2],[@B3]\]. For trimethylaminuria, at least 40 genetic polymorphisms of the *flavin-containing monooxygenase 3*(*FMO3*) gene have been reported \[[@B4],[@B5]\]. For transient trimethylaminuria, a change of metabolic capacity in one individual around the time of menstruation has been reported \[[@B6]\]. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active FMO3.

Methods
=======

Japanese female volunteers included two subjects suffering self-reported malodor that responded to an Internet article and three healthy laboratory members as controls, ranging from 21 to 37 years of age \[[@B5],[@B7]\]. Written consent was obtained from the individuals for publication of study. FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine *N*-oxide) was defined as the urinary ratio of trimethylamine *N-*oxide to total trimethylamine (% of trimethylamine *N*-oxide/\[trimethylamine + trimethylamine *N*-oxide\]) determined by GC \[[@B7]\]. The *FMO3*DNA sequence of genomic DNA prepared from peripheral lymphocytes or buccal cells from the study participants was also analyzed \[[@B3],[@B5]\]. The study participants collected their urine samples using a procedure described previously \[[@B7]\]. The ethics committee of Showa Pharmaceutical University approved this study.

Results and discussion
======================

As shown in Figure [1](#F1){ref-type="fig"}, Case (A) that was homozygous for inactive Arg500stop *FMO3*\[[@B5]\], showed decreased metabolic capacity of FMO3 (i.e., 13 ± 10 % (mean ± SD, n = 20) of the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common \[Glu158Lys; Glu308Gly\] *FMO3*polymorphisms \[[@B1]-[@B3]\], metabolic capacity of FMO3 was almost \~90%, except for a few days surrounding menstruation. In comparison, healthy control Case (C) that harbored heterozygous polymorphisms for \[Glu158Lys; Glu308Gly\] *FMO3*showed \> 90% metabolic capacity and this was greater than the reported unaffected ratio \[[@B1],[@B6],[@B7]\]. However, for Case (C), on days around menstruation the FMO3 metabolic capacity was decreased to \~60--70%. Control Cases (D) and (E) that were homozygous for wild *FMO3*also showed normal FMO3 metabolic capacity (i.e., \~\> 90%), except for days around menstruation. Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as \[Glu158Lys; Glu308Gly\] that cause a reduced FMO3 function. This would further suggest that sex hormones play a role in the variable regulation of FMO3. Induced FMO3 activity during pregnancy \[[@B8]\] has been reported, in accordance with the present results.

![Decreased metabolic capacity of FMO3 (△), as indicated as percent free trimethylamine (TMA, ●) to total trimethylamine (○) excreted in the urine, in relation to menstruation. Filled boxes indicate the period of menstruation. Total urinary trimethylamine and free trimethylamine concentrations were calculated as mmol trimethylamine (TMA)/mol creatinine. Cases (A) and (B) were self-reported subjects suffering from malodour genotyped for homozygotic inactive Arg500stop *FMO3*and homozygotic common \[Glu158Lys; Glu308Gly\] *FMO3*, respectively. Cases (C) and (D and E) were control subjects genotyped as heterozygotic for \[Glu158Lys; Glu308Gly\] *FMO3*and homozygotic for wild *FMO3*, respectively.](1471-2350-8-2-1){#F1}

Conclusion
==========

Menses can be a factor causing transient trimethylaminuria even in healthy women harboring active enzymes. The present information could be useful in relieving the symptoms for transient and/or mild trimethylaminuria for affected females during menstruation.
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